Published in:Experimental and Clinical Endocrinology & Diabetes
Language:
English
DOI:
10.1055/a-2269-1594
ISSN:
0947-7349;
1439-3646
Origination:
Footnote:
Description:
<jats:title>Abstract</jats:title><jats:p>
Background Due to a multicenter study early in the coronavirus disease
(COVID)-pandemic that revealed an increased risk for postoperative mortality,
thromboembolic and pulmonary complications in case of surgery shortly after a
COVID infection, current recommendations for planning elective surgeries suggest
postponing surgery for at least 7 weeks after COVID infection. However, virus
variants have evolved throughout the pandemic, leading to less severe symptoms.
Besides, laparoscopic adrenal gland surgery itself is a safe procedure with low
morbidity rates. Therefore, this study aimed to compare the perioperative course
of patients undergoing laparoscopic adrenalectomy shortly after a COVID-19
infection with those who had not had a recent SARS-CoV-2 infection in 2022.</jats:p><jats:p>
Patients, Material, and Methods All patients who underwent laparoscopic
adrenalectomy at the Department for General, Visceral and Transplantation
Surgery at Ludwig-Maximilian University between January and December 2022 were
included.</jats:p><jats:p>
Results There was no event of thromboembolic or pulmonary complications in
the study population. Duration of surgery did not differ between the two groups;
neither did the need for postoperative ICU-admittance nor the duration of
ICU-stay. Intraoperative FiO2 did not differ, nor did the
SpO2 or the number of different catecholamines. There was a
slight trend towards higher noradrenaline dosage among patients after COVID-19
infection. Previous COVID infection did not lead to prolonged hospital
stays.</jats:p><jats:p>
Conclusion The results demonstrate that in case of well-standardized
surgical procedures, with a limited surgical trauma and the possibility for
patients to be mobilized early, surgery shortly after a mild COVID infection
seems safe and reasonable.</jats:p>